Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Flurry of Big Pharma deals ‘makes sense’

    Apr 22, 2014, 00:00 AM by Michael Croft
    , UK - Apr 22, 2014 - Novartis and GlaxoSmithKline have agreed to exchange assets and combine their consumer healthcare units
    Full story
  • To Speed Sequencing, Edico Genome Proposes NGS Processor

    Apr 21, 2014, 07:00 AM by Michael Croft
    Bio-IT World | Of sequencing bottlenecks, the most lamented is the analysis pipeline. Edico Genome is developing the DRAGEN Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics ASIC to speed and smooth that process.
    Full story
  • Remarkable Twin Study Widens View of Down's Syndrome

    Apr 18, 2014, 08:40 AM by Michael Croft
    Bio-IT World News Brief | A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down's syndrome, using a novel cellular model of the disorder.
    Full story
  • As Genetics Moves to the Clinic, Pathogenic Variants Still Subject to Doubt and Debate

    Apr 17, 2014, 10:15 AM by Michael Croft
    Bio-IT World | Genetic diagnostics is a growing field with great promise for improving medical care—yet interpreting the results of tests is a painstaking process, and different labs can disagree on which variants contribute to disease. As open science advocates seek to collect together and curate our knowledge of disease-related genes, the reluctance of many clinical labs to share their data continues to hinder progress.
    Full story
  • Thomson Reuters Names 2014 Drugs to Watch

    Apr 17, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, US - Apr 17, 2014 -   The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, released its annual forecast of the leading drugs to watch in 2014, including three potential blockbuster treatments anticipated to attain more than $1 billion in sales through 2019, after entering the marketplace this year
    Full story
  • Titian Software to Preview Latest Version of its Leading Sample Management Software, Mosaic, at BioIT World

    Apr 16, 2014, 00:00 AM by Michael Croft
    LONDON, UNITED KINGDOM - Apr 16, 2014 - Titian Software (www.titian.co.uk) has announced that it will preview Mosaic 6.0, the latest and most advanced version of its established sample management software, at BioIT World in Boston, MA (29 April – 1 May 2014), booth #353
    Full story
  • Qlucore and Nebion collaboration will benefit researchers

    Apr 16, 2014, 00:00 AM by Michael Croft
    , UK - Apr 16, 2014 - Qlucore and Nebion collaboration will benefit researchers
     
    2014 will see Qlucore and Nebion AG working together to promote their two products Qlucore Omics Explorer and Genevestigator
    Full story
  • Novartis Out of RNAi Research

    Apr 15, 2014, 13:00 PM by Michael Croft
    Forbes | Novartis bows out of RNAi research, the second big pharma to do so.
    Full story
  • Broad Claims Patent on CRISPR Technology

    Apr 15, 2014, 09:35 AM by Michael Croft
    Bio-IT World News Brief | The U.S. Patent and Trademark Office this morning issued the first patent to cover CRISPR-Cas9 gene editing, awarding the Broad Institute a patent for a version of the CRISPR-Cas9 system used to modify the DNA of mammalian cells.
    Full story
  • Certara Acquires Specialty Contract Research Organization Synchrogenix

    Apr 15, 2014, 00:00 AM by Michael Croft
    ST. LOUIS, MO - Apr 15, 2014 - Certara™, the leading technology-enabled drug development and drug safety consultancy, announced today that it has acquired specialty contract research organization (CRO) Synchrogenix Information Strategies Inc
    Full story
  • In Last Sprint to Product Launch, Edico Genome Hints at Massively Accelerated Informatics

    Apr 14, 2014, 13:00 PM by Michael Croft
    U-T San Diego | San Diego-based Edico Genome is working on a chip-based system, the Dragen Wavefront Processor, to perform first-line analysis of genetic information in a fraction of the time required by the fastest current methods.
    Full story
  • NovoPath Debuts Web Portal for Patient Access to Test Result Reports

    Apr 14, 2014, 00:00 AM by Michael Croft
    PRINCETON, NJ - Apr 14, 2014 - NovoPath introduces a customizable web portal to its NovoPath anatomic pathology laboratory information system (APLIS), helping customers efficiently comply with new legislation requiring labs to provide direct patient access to reports
    Full story
  • iRODS 4.0 release brings popular data management tool to wider audience

    Apr 14, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Apr 14, 2014 - Chapel Hill, NC – The iRODS Consortium today announced the release of iRODS 4.0, a sustainable and production-oriented version of the iRODS (integrated Rule-Oriented Data System) data management platform
    Full story
  • KCR Launches New Service Company: KCR Placement

    Apr 14, 2014, 00:00 AM by Michael Croft
    WARSAW, POLAND - Apr 14, 2014 - Warsaw - 14 April 2014 - European Clinical Research Organization (CRO), KCR, is pleased to announce the launch of its new business enterprise: KCR Placement
    Full story
  • Bio-Rad Picks Up GnuBIO, Droplet-Based Sequencing

    Apr 11, 2014, 14:00 PM by Michael Croft
    Bio-IT World News Brief | Bio-Rad has acquired GnuBIO, a next-generation droplet-based DNA sequencing technology. GnuBIO's DNA sequencing solution integrates the entire sample preparation workflow on a chip.
    Full story
  • Duke's Plans for the Soon-to-be Defunct Institute for Genome Sciences

    Apr 10, 2014, 12:00 PM by Michael Croft
    Duke Chronicle | Duke's plans for the Institute for Genome Sciences & Policy were made public in late March--a formal dismantling July 1.
    Full story
  • FDA Grants Breakthrough Status to Gene Therapy for First Time

    Apr 10, 2014, 11:10 AM by Michael Croft
    Bio-IT World News Brief | Celladon today became the first company to receive breakthrough status for a gene therapy treatment in development. The treatment, MYDICAR, is intended to reduce the risk of heart failure in patients with a deficiency of the enzyme SERCA2a.
    Full story
  • AWS, Google, Microsoft Chop Cloud Prices

    Apr 10, 2014, 11:00 AM by Michael Croft
    Computerworld | A string of price cuts from Google, Amazon Web Services, and Microsoft has further driven down the price of cloud computing.
    Full story
  • Aspera on Life with IBM, and Bio-IT World Expo Plans

    Apr 10, 2014, 08:00 AM by Michael Croft
    Bio-IT World | A few months after Aspera's acquisition by IBM, Bio-IT World caught up with Aspera CEO Michelle Munson, a Bio-IT World Conference & Expo speaker and exhibitor, to hear the latest on life at Big Blue and what’s new in Aspera’s pipeline. 
    Full story
  • India's Open Source Experiment Short on Funds, Talent

    Apr 9, 2014, 15:00 PM by Michael Croft
    Bio-IT World Roundup | More challenges for India's Open Source Drug Development project. The Indian Ministry of Science and Technology reportedly did not clear the cabinet note meant to extend funding for the Open Source Drug Discovery project and the project is facing a serious talent shortage.
    Full story
  • «
  • 401
  • 402 (current)
  • 403
  • 404
  • 405
  • 406
  • 407
  • 408
  • 409
  • 410
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy